Results and Discussion
The general methods employed for the preparation of styryl-lactone derivatives 2-20 are outlined in Chart 1. The nitration of 1 in acetic anhydride with a mixture of concentrated nitric acid and glacial acetic acid afforded two nitrogoniothalamin derivatives, 10-nitro-goniothalamin (2) and 12-nitro-goniothalamin (3) in 52% and 11% yields, respectively.
11) Subsequent reduction of the nitro group in 2 was attempted under different sets of conditions. 12, 13) Firstly, when Fe/HCl was used as the reductant, the reactant disappeared but no target product was obtained. Then, by sodium hydrosulfite in methanol/water (90%) at room temperature (rt), 2 was reduced to 10-amino-goniothalamin (4) in a low yield of 5%. In the condition using 0.5 M stannous chloride dihydrate (14 eq) in N,N-dimethylformamide (DMF)/dichloromethane (1 : 1), 2 was successfully reduced to 4 in moderate yield (61%). Acetylization of 4 with Ac 2 O at rt gave 10-acetylamino-goniothalamin (5) in satisfactory yield (92%). 14) A suspension of the amine 4 and succinic anhydride in dry CH 2 Cl 2 was stirred at rt for 6 h to give 10-(hydroxysuccinyl)-amino-goniothalamin (6) in 60% yield. 15) The amino acid derivatives 14-20 were obtained as trifluoroacetate salts in good yield by reacting 4 with various N-tert-butoxycarbonyl (t-Boc)-protected amino acids in the presence of dicyclohexylcarbodiimide (DCC), and successive deprotection by trifluoroacetic acid (TFA) in dichloromethane. 16) All compounds were unambiguously confirmed by spectroscopic methods.
The antitumor activities of these derivatives were measured in vitro using a SRB (Sulforhodamine B) assay against human promyelocytic leukemia HL-60 and human hepatoma BEL-7402 cells. Compounds 2-5, which possessed significant activity against HL-60 cells, were selected for further evaluation against human lung carcinoma A549 and human stomach cancer SGC-7901 cells with the reference com-pound, goniothalamin. For two reasons, VP-16 (etoposide, 21) was chosen as a positive control standard. First, the etoposide is also the derivative of a naturally originated compound. Secondly, it had consecutively been used as the control standard in our previous antitumor tests of the natural styryllactones isolated from Goniothalamus plants. 9) The results, expressed as IC 50 values, are summarized in Table 2 .
In the antitumor tests, the semi-synthetic styryllactone derivatives 2, 3 and 4, as well as goniothalamin (1) showed stronger inhibitory effects (IC 50 1.07-1.56 mg/ml) than the positive control drug etoposide (IC 50 6.07 mg/ml) against the tumor cell strain SGC-7901 (human stomach tumor), even though most of the derivatives generally gave lower inhibition to HL-60, Bel-7402 tumor cell lines ( Table 2) .
The compounds 2, 3 and 4, however, showed comparable or superior activity against HL-60, A549 or SGC-7901 cells in comparison to their parent 1 ( Table 2 ). Compound 2 of the main product in nitration was chosen as the starting material for the next step reaction, and subsequent reduction easily gave the amine 4. Its antitumor activity was similar to 3. It was noticeable that the formation of the acylamino group of the 10-position made the IC 50 of the derivatives increase dramatically, from 0.64 to 3.30 mg/ml for A549 cells, and from 1.14 to 25 mg/ml for SGC-7901 cells (Table 2) . It was assumed that the carbonyl group in the acylamide distributed the lone electrons in the nitrogen because of the conjugated effect, and this indicated that the free amino group at the 10-position was favorable for its antitumor activity. Further study could explore in detail how the substituents at C-10 affect the antitumor activity after the conversion of an amino group in the amine 4 to other substituted groups. Additionally, several amino acid trifluoroacetate derivatives (15, 17, 18, 20) showed comparable activity against HL-60 cells to the amine 4, but were less active than parent 1. The data obtained indicated that the introduction of amino acid groups could not enhance the antitumor activity in vitro.
The approximate calculating logP (p value), or log of the partition coefficient, for a molecule was used for evaluating the water solubility of the derivatives. P is logarithmically related to free energy, generally expressed as logP, and is therefore the sum of the hydrophobic and hydrophilic characteristics of the organic functional groups making up the structure of the molecule. 17) According to the p value for organic fragments, [18] [19] [20] each derivative compound in this experiment was calculated and included in Table 2 . The higher logP value corresponds to the stronger hydrophobic or weaker hydrophilic nature of the molecule.
After the chemical modification, most of the amino acid derivatives of gonithalamin which possessed higher logP values (ϩ4.8 to ϩ7.3), expressed poor antitumor activities against HL-60 cells (IC 50 was 2-3 mg/ml); meanwhile the compounds 1, 2 and 3, whose logP values were ϩ4.4 to ϩ4.7, possessed good activities (IC 50 was 0.18-0.68 mg/ml). In addition, different amino moieties in the styryllactone derivatives resulted in little difference in antitumor activity. Extraction and Isolation Dried and powdered leaves (10 kg) of G. griffithii were extracted with alcohol and concentrated. The extract was dissolved in MeOH-H 2 O (1 : 9) and was extracted with petroleum. After being concentrated, 120 g of brown resin was subjected to silica gel chromatography, eluted with a gradient of petroleum/ethyl acetate, which gave goniothalamin (1) 8.0 g (colorless crystal, Rfϭ0.22 petroleum/ethyl acetate (v/v 8 : 2)), structurally confirmed by comparing its 1 H-and 13 C-NMR data with those reported.
Experimental General

6)
Bioassays Live cancer cells were established by using Trypan blue stain, and cell generation was measured by means of the SRB method. All test compounds were solubilized in DMSO. Each compound concentration was tested in quadruplicate wells. The cancer cells, cultured in 10% bovine serum, were digested with trypsin solution. The cancer cells at a concentration of 1ϫ10 5 cells/ml were inoculated into every cell of a 96-well dish and cultured at 37°C in 5% CO 2 for 48 h. The cellular proteins were precipitated to the plates with trichloroacetic acid and stained with 0.4% SRB. Protein bound SRB was solubilized with Tris base and read at 515 nm in an ELISA reader. The protein content of the compound-treated cells was compared to that of the DMSO control, and IC 50 values were obtained.
Preparation of Compounds 2 and 3
To an acetic anhydride (45 ml) solution of 1 (3050 mg, 15 mmol) was added dropwise at 0°C concentrated nitric acid and glacial acetic acid (18 ml 1 : 3) for 1.5 h. After the addition was complete, the mixture was stirred at rt for 2 h, then ice and CH 2 Cl 2 was added, and the reaction products were extracted into CH 2 Cl 2 . The residue 
10-(Hydroxysuccinyl)amino-goniothalamin (6)
A suspension of the amine 4 (15 mg, 0.07 mmol) and succinic anhydride (120 mg, 1.20 mmol) in dry CH 2 Cl 2 (3 ml) was stirred for 6 h at rt. The solids were filtered and the filtrate was concentrated and chromatographed (CHCl 3 : MeOHϭ46 : 4) to give 6 as a yellow amorphous solid (13 mg, 60%). 10-(N-a a-tert-Butoxycarbonyl-L-glycyl)amino-goniothalamin (7) To a stirred solution of 4 (30 mg, 0.14 mmol) and N-tert-butoxycarbonyl-Lglycine (147 mg, 0.84 mmol) in CH 2 Cl 2 (3.5 ml), DCC (173 mg, 0.84 mmol) was added. The reaction mixture was stirred at rt for 1.5 h and the solids were filtered. The filtrate was concentrated in vacuo and the residue was chromatographed (petroleum : ethyl acetateϭ8 : 5). Initially obtained was 7 as a white amorphous solid (40 mg, 77%). 1H, m, H-4) , 6 .80 (1H, d, Jϭ15.65 Hz, H-8), 6.15 (1H, dd, Jϭ15.65, 6.24 Hz, H-7 00 (3H, m, NH, H-7, H-3), 5.11-5.06 (1H, m, H-6 10-(a a-L-Glycyl)amino-goniothalamin Trifluoroacetate (14) To a solution of trifluoroacetic acid (0.5 ml) and methylene chloride (1.5 ml) was added 7 (18 mg, 0.05 mmol), and the mixture was stirred 1 h at rt. The solvent was removed in vacuo and the residue was chromatographed (CHCl 3 : MeOHϭ50 : 2) to give 14 as a yellow solid (11 mg, 59% 
